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Özefagogastroduedonal Endoskopi için Sedasyon
Özet
Özefagogastroduedonal endoskopi sırasında pek çok anestetik yöntem ve ilaç 
kullanılabilir. Özefagogastroduedonal endoskopi için uygulanacak sedasyon ilaç 
ve yöntemleri hakkında araştırmalar sürmektedir. Bu derlemenin amacı sedasyon 
ve özefagogastroduedonal endoskopi ve sedasyonla ilişkili konuları literature bil-
gileri ışığında tartışmaktır. Tanısal özefagogastroduedonal endoskopi için günü-
müzde kullanılan standart yöntem genellikle yüzeyel farengeal anestezi minimal 
sedasyon ya da anksiyolizdir. Gerekli olursa sonradan analjezi eklenebilir. Uzun 
süreli, karmaşık ya da sorunlu ve ağrılı işlemler için uzman denetiminde yapılan 
daha derin sedasyon yöntemleri gerekebilir.
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Abstract
Different anesthetic techniques and drugs can be used for esophagogastro-
duedonal endoscopy. However, the scientists are still searching for appropri-
ate drugs and protocols for sedation during esophagogastroduedonal endos-
copy. The aim of this review is to discuss the topics related with sedation and 
esophagogastroduedonal endoscopy in the light of literature. Today standard 
procedure for diagnostic esophagogastroduedonal endoscopy usually con-
sists of topical pharyngeal anesthesia, minimal sedation or anxiolysis, which 
may be complemented with analgesia when needed. When a prolonged, com-
plex, or particularly troublesome or painful examination is foreseen, deeper 
sedation with multiple drugs and in closed observation of a staff may be 
required.
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Introduction
Esophagogastroduodenal Endoscopy EGDE is a disturb-
ing procedure. Even sedation is not required to perform 
a technically adequate EGDE; it has been accepted as a 
standard practice for decades. The primary aim of using 
sedation is to increase the comfort both for the patient 
and endoscopist and decrease the duration of the pro-
cedure by easing the endoscopy course and increasing 
patient cooperation and willingness for future EGDE’s 
by diminishing the memory of the event. However, the 
use of sedation for endoscopic procedures varies widely 
throughout the world and there is still no consensus on 
sedation types for EGDE [1].
  It is important to examine current practice for 
increasing the quality of EGDE and sedation techniques. 
We have much experienced in rigid EGDE than colonos-
copy. So the purpose of this review is to summarize the 
characteristics of drugs used for rigid EGDE and to pres-
ent an outline for endoscopist. There is also a contro-
versy on the specialty of staff that performs sedation we 
did not criticize any suggestions on this issue.
Background
Sedation is a continuum of progressive impairment in 
consciousness that has been roughly divided into four 
different levels, ranging from anxiolysis or minimal seda-
tion to general anesthesia [2].Sedation levels according 
to the American Society of Anesthesiology (ASA) were 
shown in table 1. 
Preprocedural Preparation and Assessment
  Endoscopist  will  have  to  assess  patient  and 
procedural-related factors before reaching a decision on 
what specific type of endoscopic sedation and drug (if 
any) to use. These factors should include medical his-
tory of the patient, review of drug and food (egg, soy) 
allergies, current medications (history of antidepressant, 
neuroleptic or cardiologic agent), potential drug inter-
actions, history of adverse reaction to sedation or an-
esthesia, preoperative fasting (time and nature of last 
oral intake). History of tobacco, alcohol, or substance us-
age should also be evaluated. In addition, all women of 
childbearing age should be queried about the possibility of 
pregnancy.
The  preprocedural  airway  assessment  is  the  most  criti-
cal aspect of safe sedation practice [3]. In order to predict 
which patients may be more likely to show difficulties re-
garding airway, the following should be considered: History 
of  problems  with  previous  anesthesia,  presence  of  sleep 
apnea, snoring; facial dimorphism; oral cavity abnormali-
ties (mouth opening smaller than 3 cm, protruding incisors, 
high-arched palate, macroglossia, tonsillar hypertrophy or 
nonvisible uvula (Mallapati III-V), inability to bite upper lip 
by lower incisors, neck abnormalities (morbid obesity, short 
neck, limited neck extension, endothoracic goiter, neck mass, 
reduced hyoid-mental distance (< 3 cm)]; patients with man-
dibular abnormalities (micro-retrognatia,). 
  Patients who were not in good health (ASA>3-4) 
or had risk factors for the development of airway complica-
tions or possible airway management problems should be 
excluded. 
How to Perform an Unsedated Endoscopy?
Selected older patients, male gender, patients who are not 
anxious, may have better tolerance of upper endoscopy pa-
tients may be able to undergo EGDE without sedation by 
use  of  topical  pharyngeal  anesthesia  (TPA)  [4].  However, 
first time examinees with high scores for trait anxiety poorly 
tolerate insertion of the endoscope. In order to perform an 
unsedated endoscopy the traditional techniques consist fol-
lowing steps.
1.  Asking  to  pa-
tient  whether  he  or 
she  prefer  spray  or 
gargling before appli-
cation of TPA.
2 .   Observing  
pharyngeal  sensitiv-
ity during application 
of TPA. (Encouraging 
patient  to  say  “aah” 
is  not  recommended 
because  this  might 
expose  the  larynx  to 
the anesthetic agent and inhibits the cough reflex. )
3.  Observing patient after first puff for any adverse 
events. (Patients may swallow the anesthetic after a while.)
Maximum dose of lidocaine (1-1.5 mg/kg ) (7-10pufs) should 
be kept in mind. A high trait-anxiety score during local anes-
thesia application usually points out a difficult EGDE. 
Topical Pharyngeal Anesthesia (TPA)
  Main indication for TPA is to suppress vomiting re-
flex. Vomiting reflex during insertion of the endoscope and 
its operation in the upper gastrointestinal tract may cause 
Table 1.Sedation levels according to the American Society of Anesthesiology (ASA)
Minimal 
Sedation
(anxiolysis)
Moderate
Sedation/analgesia
(conscious sedation)
Deep
Sedation/analgesia
General 
Anesthesia
Responsiveness
Normal response to 
verbal stimulation
Purposeful* response to
verbal or tactile stimulation
Purposeful* response after 
repeated or painful stimulation
Unarousabl, even with painful 
stimulus
Airway Unaffected No intervention required
Intervention may be required
Intervention often require
Spontaneous 
ventilation
Unaffected Adequate
May be inadequate
Frequently inadequate
Cardiovascular 
function
Unaffected Usually maintained
Usually maintained
May be impaired
*Reflex withdrawal from painful stimulus is not considered a purposeful response.  Practice guidelines for sedation and analgesia by 
non-anesthesiologists. Anesthesiology 2002; 96:1004-17.Journal of Clinical and Analytical Medicine       
Esophagogastrodeudonal Endoscopy
changes in hemodynamics, oxygen saturation and au-
tonomic nervous activities, and even induce lethal dis-
rhythmia or sudden death [5, 6, 7 ].
In  clinical  practice,  topical  anesthesia  is  used  during 
unsedated EGDE. It is more beneficial for younger pa-
tients who are anxious or undergoing EGDE for the first 
time without sedation [8]. 
TPA can be applied either by spraying or gargling. Even 
patient’s preferences among TPA is favored on gargling, 
spray application may be more feasible for the proce-
dure because the anesthetic agent can be applied to the 
posterior pharyngeal wall visually. During administration 
of TPA, observing the presence of a strong gag reflex 
strongly correlates with pharyngeal sensitivity as a “real-
life” clinical practice [9]. 
Some patients may dislike its taste, the burning sensa-
tion  that  accompanies  anesthesia  and  the  anesthetic 
feeling itself [10]. Lidocaine, benzocaine, and tetracaine 
are the most commonly used topical local anesthetics in 
the endoscopy suites [11]. Traditionally spraying poste-
rior pharyngeal wall with 1-1.5 mg/kg lidocaine provides 
sufficient TPA. Commercial lidocaine sprays contains 10 
mg lidocaine per puff. Lidocaine is relatively poorly ab-
sorbed (much is swallowed) from the nasopharynx. It is 
well tolerated in the elderly patients with co morbidities. 
However, lidocaine is irritant and can cause complete 
airway obstruction due to laryngospasm [12]. Lidocaine 
lollipops are promising form of local oropharyngeal an-
esthesia for EGDE.
  Risks  of  TPA:  The  potential  complications  of 
TPA  are  mainly  laryngospasm,  anaphylactic  reactions, 
systemic toxicity (methemoglobinemia) to topical anes-
thetics, and aspiration pneumonia [13].
Because up to 25% of patients receiving pharyngeal an-
esthesia showed radiologic evidence of aspiration, TPA 
should not be used in cases with predisposing factor for 
aspiration [14,15]. It should be kept in mind that the an-
esthetic effect of TPA can last for more than 30 to 40 
minutes after the procedure. Patients should be strictly 
advised not to take any oral food and/or beverage (fast 
for about an hour) after EGDE. 
Methemoglobinemia  should  be  considered  in  patient 
who develops cyanosis after TPA especially with benzo-
caine [16]. Supplemental oxygen and Methylene blue, 1–2 
mg/kg should be administered over 5 min after, arterial 
blood gases analyses with co-oximetry. Patients with a 
glucose-6 phosphodiesterase deficiency require transfu-
sion or dialysis for treatment [17].
Intraprocedural Monitoring
  During EGDE, patients routinely positioned on 
side lying or prone and a mouth adaptor and an endo-
scope in the mouth that narrows airway and restricts 
air flow. Because hypoxemia and hypoten¬sion are the 
major reasons of major complications during EGDE, pa-
tients should be monitored for hemodynamic and respi-
ratory status. Baseline readings should be obtained at 
least four times; prior to sedation, during procedure, dur-
ing recovery and before discharge. 
Patients should be monitored with continuous electro-
cardiogram (ECG) during moderate sedation and blood 
pressure should be chequed by intervals.
The respiratory cycle of oxygenation and ventilation are 
related, but completely separate, physiologic processes. 
Human body has reserves that hold on and provides oxy-
gen for several minutes. If sedation is deep enough to 
compromise breathing, body begins to consume these 
reserves while chest continues to move up and down and 
breathing efforts of patient moves dead space air only. 
SpO2 begins to drop after body oxygen reserves con-
sumed.
From this point of view, it is not logical to expect the 
accurate level of ventilation and oxygenation breath to 
breath by pulseoximeters. To date the most pertinent in-
formation about frequency and adequacy of breathing 
during sedation is provided by capnography [18, 19, 20]. 
During  endoscope  introduction  waveforms  diminishes 
due to gag reflex. The waveform should return once the 
scope has advanced. However, a fall in SpO2 does not 
occur during introduction of endoscope.
Supplemental Oxygen
  The ASA Task Force recommends supplemental 
oxygen for moderate and deep sedation unless specifi-
cally contraindicated. However, giving supplemental oxy-
gen may cause long apnea periods in heavily sedated pa-
tients. and may result in higher rates of cardiopulmonary 
unplanned events [21]. An average 6 minutes of apnea is 
required before a healthy adult desaturates to less than 
90% [22], and 2 to 4 minutes for healthy children [23, 24, 
25]. 
Sedation  and  Analgesic  Agents  Used  for  Endos-
copy
Before deciding the appropriate agent and application 
way of sedation, it is of paramount importance to decide 
the type of endoscopic procedure (diagnostic, therapeu-
tic), the degree of pain associated with it, and the length 
of total procedure time. Diagnostic and uncomplicated 
therapeutic upper endoscopy can be performed under 
moderate  sedation.  More  complicated,  lengthy  proce-
dures and patients with special conditions may require 
deep levels of sedation. Sedation monitoring and rescue 
equipment should be available in the room. 
Benzodiazepins
  The most commonly used benzodiazepines are 
midazolam and diazepam. The efficacy of sedation with 
these 2 benzodiazepines is comparable [26]. However, 
there is a known favor on midazolam due to minimal risk 
of venous irritation and phlebitis resulting in painless İ.V. 
injection, strong anterograde amnesia and an existing 
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antidote flumazenil [27].
  Midazolam has a longer interval to peak effect 
(8–12 min versus 2–5 min) and almost 3.5 times more 
potent than diazepam. The anti-anxiety and sleep effects 
are generally manifested 1–2 min after intravenous in-
jection of 5 mg dose and anterograde amnesia effect 
becomes evident after 4 min, continuing up to 30 min 
after injection.
Standard i.v. dose for sedation induction is 0.06-0.07 
mg/kg. Esophageal intubation could successfully be per-
formed after 30 seconds and patients will not remember 
the procedure [28]. When the sedative state 30 s after i.v. 
midazolam is insufficient, appropriate additional doses 
should be administered [28]. It should be kept in mind 
that benzodiazepines are lipid-soluble (particularly mida-
zolam) and repeated doses may accumulate into the adi-
pose tissue and after subsequently releasing, prolongs 
recovery. 
Benzodiazepine combinations: Because midazolam does 
not exhibit any analgesic effects, sole use for conscious 
sedation does not suppress sympathic stimulation due to 
esophageal intubation [29]. In order to reduce the harm-
ful effects of sympathic stimulation benzodiazepines are 
usually combined with opioids. The obvious disadvan-
tage of benzodiazepine-opioid combination is respirato-
ry depression due to synergistic effect by flattening the 
carbon dioxide (CO2) response curve of the respiratory 
center. When given with fentanyl, only about 25% of the 
ED50 dose of midazolam and 25% of the ED50 dose of 
fentanyl were necessary to produce unresponsiveness. In 
past midazolam usually combined with pethidine. How-
ever, it has a slower onset of action that delays the start 
of endoscopy, longer duration of action that prolongs the 
recovery and produces more postprandial nausea and 
fatigue when compared with newer opioids. Nowadays, 
it is not realistic to use it while more suitable drugs like 
fentanyl were still exists. 
Propofol
Propofol is the most studied sedative agent for gastro-
intestinal endoscopy. It is pure sedative/hypnotic without 
analgesic properties. It has a rapid onset and offset ef-
fect time. When used for GI endoscopy, 40 to 60 mg bo-
lus doses are typically produce sedation in normal adults 
within 40 seconds ie, “1 arm-brain circulation”. Subse-
quent doses should be administered after assessment of 
responses to the initial dose, but typically given in 10- to 
20-mg increments every 1 to 2 minutes. Dose reduction 
is necessary in patients with cardiac dysfunction and in 
the elderly as a result of decreased clearance.
Therapeutic index (the difference between the doses for 
moderate and deep sedation) of propofol is very narrow. 
This means that patients may quickly slip from moder-
ate to deep sedation or to general anesthesia. Therefore, 
vigilant monitoring is necessary. 
It is a pregnancy category B drug and should be used with 
caution during lactation [30]. Vials are labeled for single-use 
only; unused portions should be discarded within 6 hours to 
decrease the risk of contamination.
Two  preparations  exist;  one  is  prepared  as  an  oil/water 
emulsion consisting of 1% propofol, 10% soybean oil, 2.25% 
glycerol, and 1.2% egg lecithin. It is contraindicated in pa-
tients with propofol allergy or hypersensitivity to eggs or 
soybean. The other preparation has bisulfates; and it is con-
traindicated  in  patients  with,  allergies/reactions  to  bisul-
fates. 
Propofol is superior to other sedatives in terms of recovery 
time, physician and patient satisfaction and psychomotor 
testing during discharge [31]. However, a benefit in this re-
gard over traditional benzodiazepine/narcotic combinations 
has not been uniformly demonstrated [32].
The total dosage needed to perform EGDE is slightly higher 
than for colonoscopies with an accompanying increased risk 
of apnea [33, 34]. Nevertheless, the short procedure time 
corresponds very well with the action of the drug. After an 
adequate level of sedation has been reached, most EGDE’s 
could be performed without further additional doses. 
  It is concluded that propofol concentration which 
suppresses the somatic response to EGDE was higher than 
the  concentration  that  suppresses  a  response  to  verbal 
command [35]. However, dose-related side effects such as 
hypotension, hypoventilation, or bradycardia are relatively 
frequent, when large doses are administered [36].
Propofol combinations
Due to the mentioned lack of analgesic effect of propofol it 
is logical to use it in conjunction with a pain-relieving drug 
(balanced anesthetic technique) [37]. In accordance with this 
data, nowadays propofol-opioid combination became an al-
ternative to the traditional benzodiazepine-opioid combina-
tion. More precise dose titration is possible with smaller bo-
lus doses of propofol (5-15 mg) and the potential for partial 
pharmacologic reversibility by  naloxone [38,39]. 
Propofol-Pethidine Combination: Pethidine prolongs the re-
covery time compared with alfentanil [40].
Propofol  Benzodiazepine  Combination:  This  regimen  was 
not superior in terms of sedation and was associated with 
longer recovery times [41]. In fact it eliminates the advan-
tage of using propofol because both drugs are sedative and 
combining two same class drugs does not produce an effect 
that each one has.
Propofol-ketamine Combination: The combination of propo-
fol  with  subhypnotic,  analgesic  dosages  of  ketamine  im-
proves patient comfort, suppress the need for supplemen-
tal opioids, reduces total propofol dose, and (in contrast to 
benzodiazepines) do not have cardiorespiratory depressant 
actions  [42]. Guit et al. [43] reported that propofol-fenta-
nyl  combination  depressed  hemodynamics,  but  propofol-
ketamine  combination  resulted  in  stable  hemodynamics. 
Therefore Propofol-Ketamine may be an effective combina-
tion during EDGE’s of patients with limited cardiac reserves. 
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Propofol-Ketamine  combination  was  associated  with 
more patient satisfaction and amnesia and a reduced 
need for restraint during fiberoptic bronchoscopy [43]. 
This suggests that the level of sedation was deeper with 
the PK combination. 
  Propofol-remifentanil Combination: Remifenta-
nil is an ultra-short acting mu-opioid receptor agonist 
with zero-order kinetics and provides dense analgesia. 
However, it has no hypnotic or amnestic properties and 
it is not suitable for patients with high anxiety levels. It 
should be used under closed supervision of anesthetist 
[44]. 
There are now two different strategies in using propofol 
for EGDE. First one is to use propofol as a routine seda-
tive for all EGDE’s in outpatient settings due to its rapid 
re-awakening and metabolism even without an anesthe-
sia staff [33, 34, 45]. However, propofol use by nonanes-
thesiologists remains a contraindication in the package 
insert of propofol in most countries. In fact there are 
some economic aspects of this tradition. These are the 
costs of anesthesia staffs and rather expensive cost of 
propofol. 
The supporters of second strategy thought that propofol 
is primarily an anesthetic agent and should be reserved 
for prolonged and difficult endoscopic procedures [46, 
47, 48]. Sedation guidelines produced by the American 
Society of Gastroenterology partially contradict those 
produced by the American Society of Anesthesiologists 
for sedation by non-anesthesiologists, whereas the Ger-
man guidelines were developed with anesthesiologists 
involved.  In  accordance  with  ASA,  it’s  our  belief  that 
propofol is an ideal agent for short diagnostic EDGE’s. 
However, it   should be used with closed observation of 
an anesthetist during long lasting therapeutic EDGE’S 
while this enables gastroenterologists to get pleasure 
of performing endoscopy without concerning of what is 
happening to the patient. 
Pediatric Endoscopy
Diagnostic and therapeutic pediatric upper gastrointes-
tinal endoscopy procedures have dramatically increased 
during  last  decades.  Gastrointestinal  endoscopy  in  an 
uncooperative child is very risky and may be associated 
with perforation of the gastrointestinal tract. Effective 
and safe sedation is crucial for this procedure. 
  The goals of anesthetic sedation regimens for 
pediatric gastrointestinal endoscopy are to ensure pa-
tient safety, immobility, comfort, successful completion, 
and amnesia of the procedure. Other goals are to maxi-
mize efficiency and contain costs [49]. The method of se-
dation is a matter of choice after careful consideration 
of a number of factors including the patient’s condition, 
ASA classification, the type of procedure, the parents’ 
and patient’s preference, and the level of cooperation of 
the patientWith proper patient selection, intravenous se-
dation is a safe and effective method for sedation in pe-
diatric endoscopy [50,51]. General anesthesia should be 
considered necessary for highly complicated procedures 
and for patients at high risk for cardiovascular complica-
tions. 
  Airway of infants and children requires a sound 
understanding and knowledge of the variations in anato-
my, physiology, and pathology in a wide age range of pa-
tients. Each case, depending on the presenting problem, 
may require a different approach to anesthesia.
The Infant Airway
The larynx is anatomically higher. Tongue is closer to the 
roof of the mouth and can easily obstruct the airway. 
Larynx  is  more  superior  so  visualization  of  laryngeal 
structures in infants is more difficult. The epiglottis is 
omega shaped, stiffer and tilted posteriorly, resulting in 
more difficulty in visualization of the vocal cords. Addi-
tionally, the trachea is more compliant than adults and 
more sensitive to dynamic compression. The cricoid car-
tilage is the narrowest part of the airway.  It is nonex-
pendable and airway edema owing to instrumentation 
may easily obstruct the airway. Oxygen reserves in the 
infant are low and oxygen consumption is high. Hypox-
emia occurs very rapidly and many times worsens by 
gastric distention.
Unlike adult patients who can receive minimal or moder-
ate sedation, the pediatric patient requires deep seda-
tion or general anesthesia [52]. Administration of seda-
tive medications should be weight based and titrated 
by response after allowing adequate time to assess the 
effects of each dose. However, there is no standard prac-
tice for anesthesia in children undergoing gastrointesti-
nal endoscopy. Communication between the endoscopist 
and the anesthesiologist is the cornerstone of successful 
endoscopy. 
Propofol in conjunction with a short acting benzodiaz-
epine such as midazolam and a narcotic such as fentanyl 
or remifentanyl may be titrated in small increments for 
intravenous sedation.
Ketamine with propofol and midazolam provides effec-
tive sedation in pediatric patients. However this regimen 
has more side effects such as cough, dizziness, vomiting, 
and diplopia. Small doses of ketamine largely spares the 
upper airway muscle tone and laryngeal reflexes 
Non-per-OS Guidelines for pediatric patients: Non-per-
OS guidelines are set forth by the ASA as well as the 
American Academy of Pediatrics in 1992, which require 
fasting for solids and breast milk 4 hours for infants 
younger than 6 months, 6 hours for those 6 to 36 months, 
and 8 hours for those older than 36 months.
Endoscopy in Pregnancy
Endoscopy is rarely required during pregnancy. If neces-
sary the procedure should be performed with the lowest 
possible dose of category B and C drugs or if possible, 
without any sedation [53]. Category D drugs may be used 
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when the benefit clearly outweighs the risks safely.
Benzodiezepines (category D)
Prolonged use of diazepam during early pregnancy has 
been associated with cleft palate and other congenital 
abnormalities. Although there are no data on the use of 
intravenous diazepam for sedation for endoscopy, it is 
best avoided. Midazolam is a category D drug, but there 
are no reports of congenital abnormalities.
Pethidine (category B): There is no reported evidence of 
teratogenicity [54].
Topical lidocaine: Topical lidocaine is appears to be safe 
during pregnancy [55].
The  potential  risks  associated  with  endoscopy  during 
pregnancy:
1.  Oversedation may cause maternal hypotension 
and hypoxia, which in turn may lead to fetal hypoxia, 
with potentially fatal consequences.
2.  The fetus may be exposed to potentially terato-
genic drugs and radiation.
3.  Care must be taken with maternal positioning 
to avoid inferior vena caval compression by the pregnant 
uterus, which can lead to decreased uterine blood flow 
and fetal hypoxia.
Because of these known risk factors the following fac-
tors should be chequed.
(1) A strong indication, particularly in high-risk pregnan-
cies.
(2) Defer endoscopy to the second trimester whenever 
possible.
(3) Try to use the lowest dose of sedative medication.
(4) Wherever possible, use category A or B drugs.
(5) Minimize procedure time.
(6) Pregnant patients should be positioned in left pelvic 
tilt or left lateral position to avoid vena caval or aortic 
compression.
(7) Fetal heart sounds should be confirmed before during 
and after sedation.
(8) Obstetric support should be available in the event of 
a pregnancy-related complication.
(9) Endoscopy should be avoided during obstetric com-
plications such as placental abruption, imminent deliv-
ery, ruptured membranes or pre-eclampsia.
Nurse-Administered Sedation
The propofol dose must be carefully titrated according 
to  the  individual  patient’s  response.  Factors  influenc-
ing dosage include age, ASA class, patient’s height and 
procedure duration. Propofol’s primary risk is its narrow 
therapeutic  range  which  necessitates  careful  patient 
monitoring. The endoscopy team should take the respon-
sibility of recussitation of the patient when necessary. 
Patient-Controlled Sedation (PCS)
The combination of propofol with an anesthetic agent has 
likewise been repeatedly shown as practical for PCS during 
colonoscopy [56]. The typical self-administered bolus con-
sists of 4.8 mg propofol and 125 µg alfentanil [40]. However 
there is lack of data for PCS during EDGE. Furthermore the 
concept of PCS depends on patient reaction to an unpleas-
ant sensation necessitating patients to be sedated at levels 
that first permit to experiences pain than control the pain. 
This technique provides an individually tailored sedation and 
may only be applicable to convenient patients who can take 
responsibility for their own sedation.
Complications of Esophagogastroduedonal Endoscopy
  The complication rate of EGDE is about 0.1% with 
cardiopulmonary  events  predominating  [57].The  majority 
of complications are due to oversedation, hypoventilation, 
vasovagal episodes, airway obstruction and aspiration [58]. 
Ascending ASA physiologic classification, age >60 years, in-
patient status, the use of supplemental oxygen, and the in-
volvement of a trainee in the procedure are the independent 
risk factors for CPC’s [4].
Aspiration: The risk of aspiration is minimal during diagnos-
tic endoscopy. Aspiration is particularly likely when protec-
tive reflexes are blunted by excessive sedation or coexisting 
diseases of patients like encephalopathy, diabetic gastropa-
resis sleep apnea syndrome, severe chronic obstructive pul-
monary disease, or coronary heart disease and in the setting 
of emergency treatment of upper gastrointestinal hemor-
rhage, and during long-lasting procedures. Satisfactory oral 
suction and airway control are mandatory issues [59]. TPA 
should be avoided [15]. In order to prevent aspiration, pa-
tients should be fasted far enough time before sedation (2 
hours for clear liquids and 6 hours for light meals) [2].
Conclusion
Today standard procedure for diagnostic EGDE usually con-
sists of topical pharyngeal anesthesia (TPA), minimal seda-
tion or anxiolysis, which may be complemented with analge-
sia when needed. When a prolonged, complex, or particularly 
troublesome or painful examination is foreseen, deeper se-
dation with multiple drugs may be required.
It is of paramount importance to use standart monitoring 
and recussitation equipment during procedure. Start with a 
low dose, assessing the response of the patient’s sedation 
level, ventilatory and cardiovascular status; and proceeding 
gradually with titration along with topical pharyngeal anes-
thesia is the most common technique used for EDGE. Pa-
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